세계의 신경 회로 시장 예측(-2030년) : 제품 유형별, 용도별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Neuronal Circuits Market is accounted for $194.7 million in 2023 and is expected to reach $701.7 million by 2030 growing at a CAGR of 20.1% during the forecast period. Neurostimulation devices, neuromodulation technologies, and other interventions for the treatment of diseases including Parkinson's disease, depression, and chronic pain. Imaging technologies, electrodes, probes, neurostimulation devices, and neurotechnological advancements are only a few of the many tools and solutions available. Understanding, modifying, and using neuronal circuits in the nervous system is the focus of the market for neuronal circuits, which includes research, development, and commercialization of associated technologies and products.

Market Dynamics:

Driver:

Growing investments in neuroscience research

Innovation and the creation of cutting-edge technology aimed at understanding and modifying neuronal networks are fueled by increased funding from governmental organizations, private investors, and pharmaceutical corporations. These investments support research exploring neurological conditions, the intricacies of brain function, and potential treatment options. Additionally, more financing enables researchers to execute longer and deeper studies, which results in the development of cutting-edge instruments and gadgets as well as the discovery of novel insights.

Restraint:

Lack of standardization

The lack of standard methods, methodologies, and reporting practices in clinical applications and research inquiries impedes the comparability and reproducibility of results. This diversity makes it difficult to understand the data, which makes it challenging to build standard processes to examine neural circuits in neurons. In addition to making it more difficult for institutions and researchers to collaborate, the lack of standards makes it more complex to convert research findings into therapeutic applications. In order to ensure data authenticity and reliability, promote interdisciplinary collaboration, and accelerate the development of neurotechnologies that may be efficiently integrated into healthcare procedures, standardization is essential.

Opportunity:

Growing aging population

Age-related neurological conditions, such as Alzheimer's disease, Parkinson's disease, and cognitive decline, are on the rise internationally in correlation with the growing number of elderly individuals. Innovative diagnostic instruments, treatment approaches, and neurostimulation devices that can address the complexities of older people's neural circuits are desperately needed as the aging population grows. Moreover, this shift in the population emphasizes the need for neuroscience research and development to provide solutions that are specifically customized to the demands of the aging population.

Threat:

Variable efficacy in clinical settings

Although treating neurological illnesses with these therapies indicates promise, variations in their efficacy may exist. The unpredictable nature of treatment outcomes is attributed to various factors, including human heterogeneity, the complex structure of neural circuits, and the dynamic nature of neurological disorders. The wider use of these technologies is hampered by the variability that presents difficulties for healthcare professionals in anticipating and maximizing the treatment response. Deeper knowledge of the unique properties of each brain circuit, individualized treatment plans, and more research to improve and standardize techniques are necessary for achieving reliable and consistent results.

COVID-19 Impact:

The pandemic-related closure of laboratories and the reallocation of resources toward pandemic-related efforts caused significant disruptions to research and development. Additionally, difficulties in attracting patients and gaining access to research sites caused delays in clinical trials for new neurotechnologies targeting neuronal circuits. Furthermore, the increased awareness of mental health issues brought on by the pandemic also resulted in increased interest in and investment in neurotechnologies addressing conditions like depression and anxiety.

The neurotechnology devices segment is expected to be the largest during the forecast period

Due to remarkable technological developments and an increasing understanding of the critical role neural circuits play in neurological functioning, neurotechnology devices held the largest market share. Brain-computer interfaces (BCIs), neural interfaces, neurostimulation devices, and neuroprosthetics are just a few instances among the many developments that are included under the broad category of neurotechnology devices. Additionally, these gadgets are leading the way in transforming neuroscience research, therapies, and diagnostics. By modifying particular neural circuits, neurostimulation devices like deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) are being used more often to treat neurological conditions.

The motor circuits segment is expected to have the highest CAGR during the forecast period

Because of the rising awareness of the complexity of motor function and the increasing demand for cutting-edge therapeutic treatments, the motor circuits segment is expected to grow profitably. The development and use of neurotechnologies that target motor circuits, which emphasize the critical role these circuits play in movement control and coordination, is especially notable for this surge. Furthermore, the Motor Circuits portion covers advancements in neuroprosthetics and brain-computer interfaces (BCIs) that directly interface with motor-related neural circuits, providing motor function for individuals who lose their limbs or are paralyzed.

Region with largest share:

The Asia Pacific area held the largest share because of the region's countries' leading positions in the field of neurotechnology innovation, which have been established by significant investments in research and development as well as rapid improvements in healthcare infrastructure. The need for innovative diagnostic and treatment approaches has increased due to an increasing understanding of neurological illnesses and the incidence of illnesses affecting neural circuits. Furthermore, a vibrant ecosystem for neuroscience research is being developed in the Asia-Pacific area through a rise in cooperative initiatives and partnerships between academic institutions, research organizations, and industrial contributors.

Region with highest CAGR:

Because of its heavy emphasis on research funding, healthcare infrastructure, and collaborations, the Europe area is expected to have lucrative growth. European nations have invested heavily in neural circuit research, resulting in advances in the understanding of how the brain works as well as the development of cutting-edge technologies. Furthermore, the growth of cutting-edge neural circuit technology has been fueled by government financing and strategic investments in neuroscience initiatives, which have established a favorable environment for research and development.

Key players in the market:

Some of the key players in Neuronal Circuits market include BIOPAC Systems, Inc, Blackrock Microsystems, Brain Vision LLC, Cortera Neurotechnologies, Inc, CortiCare, Inc, G.tec medical engineering GmbH, Inscopix, Inc, Neuralink Corporation , Neurologica Corporation, NeuroNexus Technologies, NeuroPace, Inc and Stoelting Co.

Key Developments:

In January 2023, NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology. The partnership aims to push the boundaries of medical imaging, impact patient outcomes and increase the quality of life for Scottish patients at Dundee.

In November 2022, NeuroLogica Announces FDA 510(k) Clearance of BodyTom 64. The BodyTom 64 was designed to help healthcare professionals bring the power of advanced imaging directly to their patients.

Product Types Covered:

• Neurotechnology Devices
• Neurodiagnostics
• Neurotherapeutics
• Electrodes and Probes
• Neurostimulation Devices
• Neurotransmitter Detection Devices
• Other Product Types

Types Covered:

• Cognitive Circuits
• Motor Circuits
• Reward Circuits
• Sensory Circuits
• Other Types

Applications Covered:

• Clinical Diagnostics
• Drug Discovery and Development
• Therapeutic Interventions
• Neuroprosthetics
• Other Applications

End Users Covered:

• Hospitals
• Research and Development
• Rehabilitation Centers
• Pharmaceutical Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Neuronal Circuits Market, By Product Type

• 5.1 Introduction
• 5.2 Neurotechnology Devices
• 5.3 Neurodiagnostics
• 5.4 Neurotherapeutics
• 5.5 Electrodes and Probes
  • 5.5.1 Microelectrode arrays
  • 5.5.2 Multielectrode arrays
  • 5.5.3 Patch-clamp electrodes
• 5.6 Neurostimulation Devices
  • 5.6.1 Deep Brain Stimulation (DBS)
  • 5.6.2 Transcranial Magnetic Stimulation (TMS)
  • 5.6.3 Transcranial Direct Current Stimulation (tDCS)
• 5.7 Neurotransmitter Detection Devices
• 5.8 Other Product Types

6 Global Neuronal Circuits Market, By Type

• 6.1 Introduction
• 6.2 Cognitive Circuits
• 6.3 Motor Circuits
• 6.4 Reward Circuits
• 6.5 Sensory Circuits
• 6.6 Other Types

7 Global Neuronal Circuits Market, By Application

• 7.1 Introduction
• 7.2 Clinical Diagnostics
• 7.3 Drug Discovery and Development
• 7.4 Therapeutic Interventions
• 7.5 Neuroprosthetics
• 7.6 Other Applications

8 Global Neuronal Circuits Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Research and Development
• 8.4 Rehabilitation Centers
• 8.5 Pharmaceutical Companies
• 8.6 Other End Users

9 Global Neuronal Circuits Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 BIOPAC Systems, Inc
• 11.2 Blackrock Microsystems
• 11.3 Brain Vision LLC
• 11.4 Cortera Neurotechnologies, Inc
• 11.5 CortiCare, Inc
• 11.6 G.tec medical engineering GmbH
• 11.7 Inscopix, Inc
• 11.8 Neuralink Corporation
• 11.9 Neurologica Corporation
• 11.10 NeuroNexus Technologies
• 11.11 NeuroPace, Inc
• 11.12 Stoelting Co